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Abstract Paternal environmental conditions can influence phenotypes in future generations, but
it is unclear whether offspring phenotypes represent specific responses to particular aspects of the
paternal exposure history, or a generic response to paternal ‘quality of life’. Here, we establish a
paternal effect model based on nicotine exposure in mice, enabling pharmacological interrogation
of the specificity of the offspring response. Paternal exposure to nicotine prior to reproduction
induced a broad protective response to multiple xenobiotics in male offspring. This effect
manifested as increased survival following injection of toxic levels of either nicotine or cocaine,
accompanied by hepatic upregulation of xenobiotic processing genes, and enhanced drug
clearance. Surprisingly, this protective effect could also be induced by a nicotinic receptor
antagonist, suggesting that xenobiotic exposure, rather than nicotinic receptor signaling, is
responsible for programming offspring drug resistance. Thus, paternal drug exposure induces a
protective phenotype in offspring by enhancing metabolic tolerance to xenobiotics.
DOI: 10.7554/eLife.24771.001
Introduction
Environmental conditions experienced in one generation can affect phenotypes that manifest in
future generations, a phenomenon sometimes referred to as the ‘inheritance of acquired characters.’
In mammals, a substantial body of literature links various maternal exposures to offspring pheno-
types (Harris and Seckl, 2011; Rando and Simmons, 2015; Simmons, 2011), and an increasing
number of studies have shown that paternal environment can also alter offspring phenotype
(Rando, 2012). Paternal effect paradigms are of particular mechanistic interest in mammals, given
that it is challenging to disentangle maternal environment effects on the oocyte epigenome from
effects on uterine provisioning during offspring development. In contrast, in many paternal effect
paradigms, males contribute little more than sperm to the offspring, simplifying the search for the
mechanistic underpinnings of paternal effects on children. A large number of paternal exposure
paradigms have been used to show that a father’s diet can affect metabolic phenotypes in the next
generation (McPherson et al., 2014; Rando, 2012), while another large group of studies link pater-
nal stress (using paradigms such as social defeat stress, or early maternal separation) to anxiety-
related behaviors and cortisol release in offspring (Bale, 2015). Finally, a growing number of toxins
and drugs have been shown to induce effects on various offspring phenotypes (Skinner et al., 2011;
Vassoler et al., 2013; Yohn et al., 2015; Zeybel et al., 2012).
A key challenge in such studies at present is to understand how the offspring phenotype is
related to the stimulus presented in the paternal generation – in other words, how specific is the off-
spring response? This challenge is compounded by the fact that many of the stimuli used for
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paternal effect paradigms – low protein and high fat diets, social stressors, and endocrine disruptors
– have pleiotropic effects on organismal physiology. We therefore sought to develop a paternal
effect paradigm based on a defined ligand-receptor interaction, to enable pharmacological interro-
gation of the specificity of the offspring phenotype. Nicotine is a commonly-used drug in humans,
and acts by binding to and activating nicotinic acetylcholine receptors (nAChRs), ligand-gated cation
channels normally activated by the endogenous neurotransmitter acetylcholine. Maternal use of nico-
tine has been linked to multiple phenotypes in offspring (Yohn et al., 2015; Zhu et al., 2014), and
although effects of paternal nicotine exposure have been less-studied, paternal smoking in humans
has been suggested to affect metabolic phenotypes in children (Pembrey et al., 2006).
Here, we develop a rodent model for paternal nicotine effects, asking (1) whether exposure of
male mice to nicotine could impact phenotypes in offspring, and (2) whether any affected phenotype
would be specific for nicotine. We found that paternal exposure to nicotine induced a protective
response in the next generation, as male offspring of nicotine-exposed fathers exhibited significant
protection from nicotine toxicity. Importantly, this toxin resistance was not specific to nicotine,
instead reflecting a more general xenobiotic response – offspring of nicotine-exposed fathers exhib-
ited increased hepatic expression of a variety of genes involved in clearance of xenobiotics, and
these animals were resistant to cocaine as well as to nicotine toxicity. Finally, we found that
enhanced resistance to nicotine toxicity was also observed in offspring of males treated with the nic-
otine antagonist mecamylamine, strongly suggesting that drug resistance in offspring is a common
outcome of paternal exposure to multiple xenobiotics rather than a specific response arising from
nicotine signaling. Taken together, our results describe a novel paternal effect paradigm, and dem-
onstrate that in the case of paternal nicotine exposure, the phenotype observed in offspring is a rela-
tively generic response – enhanced xenobiotic resistance – rather than a selective downregulation of
the specific molecular pathway subject to paternal perturbation.
eLife digest Until recently, it seemed impossible that the conditions a person or animal
experiences during their lifetime might affect the health of their offspring and future generations.
Research over the past decade, however, has shown that a parent’s environment can cause changes
that can be passed to future generations. For example, studies in rodents have shown that a father’s
diet influences the way their offspring metabolize food. Moreover, a male mouse exposed to stress
or toxins fathers pups that often respond differently in stressful situations relative to other mice.
So, how do these traits get transferred to offspring via sperm and how specific is the next
generation’s response to the environmental pressures faced by their fathers? Many studies so far
have looked at environmental influences that may have broad biological effects, for example a high
fat diet. Now, some scientists are trying to understand whether exposure to nicotine, which has a
more targeted effect, causes drug-specific effects in offspring.
Vallaster et al. now show that mice whose fathers had been exposed to nicotine before mating
are more able to withstand toxic levels of the chemical than mice whose fathers were never exposed
to the drug. In the experiments, some male mice were given water with nicotine in it over the course
of five weeks. Later, the offspring of these mice were exposed to nicotine to see whether they were
more or less sensitive to it than offspring of unexposed males. It turns out the mice with nicotine-
exposed fathers have a higher resistance to the toxic effects of nicotine and, unexpectedly, to toxic
levels of cocaine as well. This suggests that the pups of nicotine-exposed fathers are not specifically
programmed to respond to nicotine, but instead are more resistant to toxins in general.
Vallaster et al. found that the livers of the offspring of nicotine-exposed fathers appear to be
better able to metabolize both drugs. Exposing the fathers to another drug called mecamylamine
(which can prevent many of nicotine’s effects on the body) also made their offspring more resistant
to nicotine, showing that multiple drugs may make offspring more toxin-resistant. Studies in humans
will be needed to confirm whether a father’s nicotine use affects children the same way it does mice.
Similar mice studies also may help scientists to study how other types of environmental exposure
might affect a man’s future children.
DOI: 10.7554/eLife.24771.002
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Results
Effects of paternal exposure history on offspring nicotine sensitivity
We established a paternal exposure paradigm in which male mice were either provided with nicotine
hydrogen tartrate (nicotine 200 mg/ml free base, sweetened with saccharine) in their drinking water,
or a control solution of tartaric acid and saccharine. Mice consumed nicotine or control solutions
(NIC or TA, respectively) from 3 weeks of age until 8 weeks of age. As previously described (Zhao-
Shea et al., 2015), this administration regimen maintains a high level of nicotine in the bloodstream
(Figure 1—figure supplement 1A–B), and results in nicotine dependence in exposed animals (Zhao-
Shea et al., 2013). Males were then withdrawn from nicotine for one week prior to mating in order
to prevent any potential for seminal fluid transmission of nicotine (the half-life of nicotine in mice
is ~10 min, the half-life of its ‘long-lived’ metabolite cotinine is ~40 min [Siu and Tyndale, 2007]).
Nicotine and control males were then mated with control females. Overall, we observed no differ-
ence in average size or sex ratio of litters arising from control or nicotine matings, or in offspring
body weights (Figure 1—figure supplement 1C–F).
We first sought to determine whether the enforced nicotine withdrawal in our exposure paradigm
might result in a paternal stress response that could affect the phenotype of progeny. As anxiety-
related behaviors have been reported in offspring of males subject to several distinct stress para-
digms (Dietz et al., 2011; Gapp et al., 2014; Short et al., 2016) (albeit not all such paradigms –
[Rodgers et al., 2013]), we therefore assessed anxiety behaviors in TA and NIC offspring. Impor-
tantly, we observed no differences between TA and NIC offspring in time spent in the center during
an open field anxiety test, or in time spent or number of entries into the open arms of an elevated
plus maze (Figure 1—figure supplement 2). These results and results discussed below (see Figure
6) indicate that our nicotine administration paradigm does not induce a stress response robustly
enough, or for long enough prior to mating, to affect offspring phenotype.
We next asked whether paternal nicotine administration could more specifically affect nicotine-
related phenotypes in the next generation. We first focused on a physiological readout of offspring
sensitivity to nicotine, using a well-established assay for suppression of locomotor activity by acute
nicotine administration (Tapper et al., 2004). Briefly, after acclimating animals to a saline injection
protocol for three days, animals are injected with either nicotine (1.5 mg/kg) or saline, and immedi-
ately introduced to a novel environment. Saline-injected animals actively explore the novel environ-
ment, and locomotor activity is quantified over a 40 min time course (Figure 1 – Baseline). In this
paradigm, injection of nicotine results in rapid suppression of locomotor activity, followed by a grad-
ual recovery of exploratory behavior over the time course of the assay. Using this assay, we observed
no significant difference in nicotine sensitivity between TA and NIC offspring, either for male or
female offspring (Figure 1, Figure 1—figure supplement 3). We therefore conclude that the acute
locomotor suppression response to nicotine is not altered by our paternal nicotine exposure
paradigm.
We next sought to identify any effects of paternal nicotine exposure on nicotine reinforcement in
offspring using an operant self-administration assay (Fowler et al., 2011). Here, after surgical
implantation of a catheter into the superior vena cava, animals are subject to caloric restriction and
trained to nose-poke an active portal to self-administer (SA) sucrose. TA and NIC offspring exhibited
similar behavior during the training period, with the exception of a modest albeit significant differ-
ence in sucrose SA on the final day of dietary training (Figure 2—figure supplement 1). After seven
days of food shaping, animals were placed in the operant chamber, a nicotine infusion pump was
connected to the central catheter, and the dietary reward for nose-poking the active portal was
replaced with a nicotine infusion. The amount of nicotine self-administered every day was then mea-
sured per session over the course of 35 days, with the nicotine infusion dose increasing every 4–8
days (Materials and methods). Overall, there was no difference in daily nicotine SA between off-
spring of control males and offspring of nicotine-exposed males (Figure 2A), indicating that nicotine
reward behavior is not significantly reprogrammed by our paternal exposure paradigm.
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Offspring of nicotine-treated males exhibit enhanced resistance to
nicotine toxicity
Nonetheless, a clear phenotype emerged serendipitously from the SA paradigm. We found that in
our strain background, the escalating nicotine dosing schedule of SA resulted in death of nearly all
animals tested at the highest doses used. Surprisingly, NIC offspring survived for many more days,
on average, than TA offspring (Figure 2B). This difference in survival was highly significant (Gehan-
Breslow-Wilcoxon p<0.0001). As there was no difference in the daily levels of nicotine administered
by either group (Figure 2A), this result suggests that paternal nicotine exposure can protect off-
spring from nicotine toxicity.
Figure 1. Nicotine suppression of locomotor activity is unaffected by paternal nicotine history. Nicotine effects on locomotor activity were assayed in
male offspring of control (TA) or nicotine-exposed (NIC) fathers. Data for females and alternative administration regimens are shown in Figure 1—
figure supplement 3. For each plot, males were injected with either saline or nicotine immediately prior to being placed in a novel environment for 40
min, during which locomotor activity was assessed by the number of times the animal interrupted a light beam during each minute. Each time point
shows the number of beam crossings in that minute, shown as average plus/minus s.e.m. for all animals tested. Importantly, here and throughout the
manuscript, the listed number of animals represent the number of litters analyzed, as we only assess one animal per litter in a given assay. Data are
shown for saline injection (‘Baseline’) – exploratory behavior decreases over time in saline-injected animals as they habituate to the locomotor cage –
and for 1.5 mg/kg nicotine injection in animals naı¨ve to nicotine (Day 1) or following five or eight prior days of the same nicotine injection and
locomotor assessment protocol.
DOI: 10.7554/eLife.24771.003
The following figure supplements are available for figure 1:
Figure supplement 1. Physiological effects of nicotine exposure on treated males.
DOI: 10.7554/eLife.24771.004
Figure supplement 2. Paternal nicotine exposure does not affect offspring anxiety-related behaviors.
DOI: 10.7554/eLife.24771.005
Figure supplement 3. No significant effects of paternal nicotine exposure on offspring locomotor response to nicotine.
DOI: 10.7554/eLife.24771.006
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As TA and NIC offspring exhibit differences in their resistance to lethal doses of nicotine despite
no difference in the daily level of nicotine consumed, we asked whether the effect of paternal nico-
tine exposure on offspring survival could be recapitulated using a single dose nicotine challenge,
rather than the laborious self-administration protocol described above. This nicotine challenge was
performed using two distinct paradigms. First, we simply challenged offspring of control or nicotine
fathers with a single dose injection of nicotine – these ‘naı¨ve’ animals had had no prior direct expo-
sure to nicotine. In addition, we reasoned that since the animals in the self-administration paradigm
were consuming nicotine for several weeks prior to eventual exposure to lethal levels of the drug
(Figure 2B), this would be expected to substantially alter nicotine-related biology in the tested ani-
mal. We therefore also subjected TA and NIC offspring to one week of chronic low-dose nicotine
(supplied in the drinking water) – we refer to these animals as the ‘chronic’ cohort – then challenged
these animals with an injection of a single LD50 dose of nicotine.
As shown in Figure 3A, naı¨ve TA and NIC offspring exhibited no significant difference in suscepti-
bility to a toxic nicotine injection, indicating that paternal nicotine exposure does not program a con-
stitutively nicotine-resistant state. In contrast, and consistent with the results of the self-
administration test, male (but not female) offspring of nicotine-exposed fathers became significantly
more tolerant to a lethal nicotine challenge than control offspring (Figure 3B), but only once they
had become acclimated to a week of chronic nicotine. Taken together, these data demonstrate that
Figure 2. Paternal experience affects nicotine toxicity, but not self-administration, in offspring. (A) Paternal nicotine exposure does not affect nicotine
self-administration in offspring. Each day, a mouse trained to self-administer nicotine (Materials and methods) was connected to the self-administration
apparatus for one hour, with the dose of nicotine administered via cannula for every correct nose poke ramping up every 4–8 days, as indicated. Total
nicotine self-administered is shown for each day of the protocol as average and s.e.m. Note that the numbers of animals participating in the trial
decreased over time due to removal from the protocol (clogged catheter) or death – the listed n represents all animals that remained on the protocol
until death. (B) Offspring of nicotine-exposed fathers exhibit significant protection from nicotine toxicity. Survival curve is shown for all animals on the
self-administration protocol (underlying data are provided in Figure 2—source data 1). Nicotine offspring exhibited significantly increased survival
during the time course of the assay relative to control offspring (Kaplan-Meyer survival curve, p<0.0001 for both Log-rank test and Gehan-Breslow-
Wilcoxon test).
DOI: 10.7554/eLife.24771.007
The following source data and figure supplement are available for figure 2:
Source data 1. Offspring of nicotine-exposed fathers exhibit significant protection from nicotine toxicity.
DOI: 10.7554/eLife.24771.008
Figure supplement 1. Modest effect of paternal nicotine exposure on dietary training.
DOI: 10.7554/eLife.24771.009
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male offspring of nicotine-exposed fathers exhibit an enhanced ability to develop tolerance to toxic
doses of nicotine, but that this tolerance is only revealed following prior exposure to sub-lethal levels
of nicotine.
Paternal nicotine exposure affects xenobiotic clearance in offspring
What is the physiological basis for the enhanced resistance to nicotine toxicity observed in NIC off-
spring relative to TA offspring? Lethal doses of nicotine induce seizures originating in the hippocam-
pus (Fonck et al., 2003). Resistance to such seizures could result from highly specific resistance
mechanisms such as downregulation of nicotinic acetylcholine receptors in the hippocampus, or
from relatively nonspecific resistance mechanisms such as enhanced detoxification of xenobiotics in
the liver. Although we cannot definitively rule out a neural basis for the enhanced nicotine resistance
observed in NIC offspring, several lines of evidence – including extensive RNA-Seq analysis of iso-
lated hippocampus – argue against this resistance resulting from altered neural physiology (Fig-
ure 4—figure supplement 1, Supplementary file 1).
In contrast to the lack of relevant molecular changes observed in the brains of NIC offspring, we
discovered a significant effect of paternal nicotine exposure on hepatic detoxification of nicotine in
offspring. As shown in Figure 4A, nicotine-acclimated NIC offspring exhibit significantly higher levels
of the long-lived nicotine metabolite cotinine at earlier time points after nicotine injection than do
TA offspring. This finding is consistent with enhanced nicotine clearance underlying the nicotine
resistance phenotype displayed by these animals, suggesting that paternal nicotine exposure pro-
grams a state of enhanced metabolic tolerance in offspring.
What is the molecular basis for the enhanced nicotine detoxification observed in NIC offspring?
As the liver is the primary site of nicotine and other xenobiotic clearance in mammals, we investi-
gated changes in mRNA abundance in hepatocytes isolated from TA and NIC offspring (Figure 4B–
C, Supplementary file 2). Paternal nicotine exposure significantly (adjusted p<0.05) affected the
expression levels of 51 genes, with upregulated genes being significantly enriched for those involved
in lipid metabolism (p=3.9e-14), amino acid catabolism (p=6.6e-8), and various mitochondrial anno-
tations including mitochondrial membrane (p=1.9e-7) (Figure 4D–E, Figure 4—figure supplement
Figure 3. Paternally-induced protection from nicotine toxicity is primed by nicotine exposure in offspring. (A) Survival of TA or NIC offspring following a
single injection of nicotine at the indicated dose. Above each bar, fraction shows the number of surviving animals over number of animals injected. For
all four doses tested, there was no significant difference in toxicity between TA and NIC offspring (p>0.7 across all four doses for males, p>0.8 for
females). (B) Survival of TA and NIC offspring following a single injection of nicotine at roughly the LD50 for naı¨ve animals in (A) – 7.2 mg/kg for male
offspring, shown in the top panel, 5.04 mg/kg for females, shown in the bottom panel. Here, offspring were acclimated to chronic nicotine in their
drinking water for 6 days, with nicotine challenge being administered 24 hr following the last day of nicotine consumption.
DOI: 10.7554/eLife.24771.010
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Figure 4. Paternal nicotine exposure induces an exaggerated protective response to xenobiotics. (A) Paternal nicotine exposure enhances nicotine
metabolism in offspring. Male TA and NIC offspring were acclimated to nicotine for 6 days, then 24 hr later were injected with 1.5 mg/kg nicotine.
Serum levels of the long-lived nicotine metabolite cotinine were measured at the indicated times after nicotine injection, with significantly (p<0.0002,
t-test with Holm-Sidak correction) elevated cotinine levels being observed at the earliest time point analyzed, indicating enhanced nicotine clearance in
NIC offspring. (B) Schematic of hepatocyte RNA-Seq experiment. (C) Cluster of hepatocyte RNA-Seq dataset. For each paternal treatment group (TA or
Figure 4 continued on next page
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2A–B). Most notably, given the nicotine resistance observed at the organismal level, NIC hepato-
cytes also exhibited increased expression of genes involved in drug metabolism (p=4.3e-6), with
upregulated genes including ‘Phase I’ (Cyp1a2, Cyp2c68) and ‘Phase II’ (Ugt2a3, Ugt2b1, Sult1d1,
and Sult1a1) detoxification enzymes, ‘Phase III’ membrane transporters (Slco1a4), as well as genes
encoding the xenobiotic-responsive nuclear hormone receptors CAR and PXR (Nr1h3 and Nr1i2)
(Figure 4C–D). In addition, the primary cytochrome involved in nicotine clearance in rodents,
Cyp2a5, was upregulated ~2 fold on average in NIC hepatocytes. Although this upregulation was
not significant (adjusted p=0.2) in the genome-wide dataset due to sample to sample variability in
expression of this gene, we validated upregulation of Cyp2a5 in additional intact livers (n = 6 NIC,
n = 4 TA, p<0.01) by q-RT-PCR (Figure 4—figure supplement 2C).
These gene expression studies thus reveal that, relative to TA hepatocytes, NIC hepatocytes
exhibit a general derepression of target genes for a broad range of nuclear hormone receptors. To
investigate the mechanistic basis for this derepression, we characterized open chromatin genome-
wide in TA and NIC hepatocytes (n = 8 samples each) using ATAC-Seq (Buenrostro et al., 2015).
Our ATAC-Seq dataset exhibited expected features such as strong peaks of accessibility over pro-
moters and other regulatory elements (Figure 4—figure supplement 3). Comparing TA and NIC
datasets, we observed a consistent global difference in overall chromatin accessibility – normalized
ATAC peaks at regulatory elements were nearly 2-fold higher in NIC hepatocytes than in TA hepato-
cytes, while TA hepatocytes exhibited a consistently higher background of transposition throughout
regions of the genome distant from regulatory elements (Figure 4—figure supplement 3A–C).
Whatever the basis for this global change in chromatin accessibility, we additionally identified 1861
peaks of chromatin accessibility (Figure 4F, Figure 4—figure supplement 3D–H,
Supplementary file 3) that differ significantly between TA and NIC hepatocytes after correcting for
the global difference in peak height between these samples. Consistent with the changes in mRNA
abundance observed in hepatocytes, these peaks were significantly enriched near genes involved in
lipid metabolism (p=2.8e-18) and xenobiotic metabolism (p=1.3e-6), along with many related GO
categories. We conclude that a history of paternal drug exposure can influence the chromatin land-
scape of hepatocytes in offspring, resulting in a broad increase in accessibility at regulatory elements
involved in metabolism and detoxification.
Enhanced xenobiotic resistance in NIC offspring is not specific for
nicotine
Importantly, the gene expression program observed in isolated hepatocytes includes a broad variety
of genes associated with drug metabolism, most of which are not specific for nicotine clearance. To
test the hypothesis that the nicotine-resistant state of NIC offspring reflects a general xenobiotic
response, rather than a nicotine-specific detoxification pathway, we asked whether NIC offspring
also exhibit enhanced resistance to another toxic challenge, cocaine. As cocaine and nicotine
Figure 4 continued
NIC), data are shown for ten individual male offspring from ten separate litters, with hepatocytes from five animals also being cultured for varying times
(0 to 21 hr) following isolation. Data are z score normalized for each culture time point. The heatmap shows 60 genes (filtered for average
expression >25 ppm) changing with a multiple hypothesis-corrected p value<0.1. Underlying data are provided in Figure 4—source data 1. (D) Genes
upregulated in NIC offspring encode enzymes involved in all three phases of xenobiotic metabolism, as indicated. (E) Selected Gene Ontology
categories enriched among genes upregulated (adjusted p<0.1) in NIC hepatocytes. (F) ATAC-Seq coverage for TA and NIC hepatocytes, as indicated,
across Nr1i3. See also Figure 4—figure supplement 3.
DOI: 10.7554/eLife.24771.011
The following source data and figure supplements are available for figure 4:
Source data 1. Cluster of hepatocyte RNA-Seq dataset.
DOI: 10.7554/eLife.24771.012
Figure supplement 1. Paternal nicotine has no significant effects on offspring hippocampal gene regulation or neural activity.
DOI: 10.7554/eLife.24771.013
Figure supplement 2. Paternal nicotine exposure affects multiple phenotypes in offspring.
DOI: 10.7554/eLife.24771.014
Figure supplement 3. Global differences in hepatocyte chromatin architecture between TA and NIC offspring.
DOI: 10.7554/eLife.24771.015
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operate through distinct molecular pathways – cocaine prevents dopamine reuptake at the synaptic
cleft by binding to and blocking the dopamine transporter, while nicotine activates and desensitizes
nicotinic acetylcholine receptors – a finding of enhanced tolerance to cocaine would strongly argue
against NIC offspring exhibiting specific epigenetic effects on the direct molecular receptor for
nicotine.
We first assessed cocaine toxicity in ‘naı¨ve’ animals that had not been previously directly exposed
to nicotine or cocaine. Similar to our findings with nicotine toxicity (Figure 3A), naı¨ve NIC and TA
animals did not exhibit significant differences in their resistance to cocaine toxicity (Figure 5A). How-
ever, as the enhanced ability of NIC offspring to survive toxic nicotine levels was only revealed fol-
lowing pre-exposure of these animals to sub-lethal doses of nicotine (Figure 3B), we next sought to
determine whether acclimation of NIC offspring to cocaine could induce a cocaine-resistant state.
To address this question, TA and NIC offspring were chronically treated with sub-lethal doses of
Figure 5. NIC offspring are protected from multiple xenobiotics. (A) Paternal nicotine exposure does not affect susceptibility of drug-naı¨ve offspring to
cocaine toxicity. Male TA and NIC offspring were injected with a single 100 mg/kg dose of cocaine. Survival is shown as in Figure 3. (B) Acclimation of
TA and NIC offspring to either nicotine or to cocaine reveals protective effect of paternal nicotine exposure on offspring cocaine resistance. As in (A),
for male offspring acclimated to chronic nicotine (200 mg/mL nicotine free-base in drinking water for six days) or cocaine (twice-daily injections with 15
mg/kg cocaine for five days). Twenty-four hours following final drug exposure, animals were injected with a single 100 mg/kg dose of cocaine. (C)
Cocaine acclimation induces nicotine resistance in NIC offspring. Here, male TA and NIC offspring were acclimated to cocaine injections (twice-daily,
15 mg/kg) over five days. Twenty-four hours after the final cocaine injection, animals were injected with 7.2 mg/kg nicotine.
DOI: 10.7554/eLife.24771.016
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cocaine – twice-daily injections of 15 mg/kg cocaine for five days – prior to challenge with a toxic
dose of cocaine. Astonishingly, this acclimation protocol resulted in enhanced resistance to cocaine
toxicity in NIC offspring, relative to TA controls (Figure 5B), revealing that NIC offspring are hyper-
responsive to multiple xenobiotics.
We next asked whether the process of acclimation to sub-lethal doses of nicotine or cocaine indu-
ces a drug-specific resistant state in NIC offspring. In other words, does pre-acclimation of NIC off-
spring to different molecules induce resistance specifically to the drug to which the animals were
exposed, or do chronic exposures to multiple distinct drugs all induce a common state of general
xenobiotic resistance? To distinguish these possibilities, we pre-acclimated TA and NIC offspring to
either nicotine or cocaine, then challenged acclimated animals with a lethal dose of the drug to
which they had not yet been exposed. Consistent with the hypothesis that drug acclimation induces
a general xenobiotic response, we found that pre-acclimation to nicotine induced a cocaine-resistant
phenotype in NIC offspring, and, conversely, that chronic cocaine could induce nicotine resistance
(Figure 5B–C). Together, these data suggest that paternal nicotine exposure programs a hyper-
responsive state in male offspring in which chronic xenobiotic exposure results in a generalized toxin
resistance.
Drug resistance is induced by multiple paternal drug exposures
The revelation that nicotine resistance in NIC offspring reflects a somewhat generic xenobiotic resis-
tance program (Figures 4C–D and 5) raises the question of what aspect of the paternal nicotine
exposure paradigm is responsible for programming the offspring phenotype. The nicotine exposure
paradigm utilized here induces nicotinic acetylcholine receptor (nAChR) signaling, with several physi-
ological consequences: (1) nicotine dependence, (2) reduced caloric intake, and (3) physiological
withdrawal resulting from the removal of nicotine for the final week prior to mating. To investigate
the role of nAChR signaling in the paternal induction of offspring drug resistance, we made use of
mecamylamine, a non-selective, non-competitive antagonist of nAChRs that readily crosses the
blood-brain barrier.
Male mice were provided with 2.0 mg/kg/day mecamylamine via a surgically-implanted infusion
pump, and mecamylamine-treated mice were split to either nicotine or TA drinking water, as in our
primary nicotine exposure paradigm. Studies have previously shown that mecamylamine administra-
tion prevents known physiological responses to nicotine such as nicotine-induced anorexia
(Mineur et al., 2011), hypothermia and locomotor effects (Tapper et al., 2004), and nicotine rein-
forcement (Corrigall and Coen, 1989). Male offspring of these fathers were then acclimated to nico-
tine for 6 days, then subject to a toxic nicotine challenge, as in Figures 3 and 5. Surprisingly, male
mice concurrently treated with nicotine and its antagonist fathered offspring with the same
enhanced nicotine resistance seen in NIC offspring (Figure 6). Importantly, this finding rigorously
rules out the possibility that our nicotine exposure paradigm induces paternal effects on offspring as
a consequence of the nicotine withdrawal stress imposed in the week before mating.
Moreover, the drug resistance observed in nicotine+mecamylamine offspring strongly argues that
this paternal effect does not even require nicotine signaling in treated fathers, instead suggesting
that the paternal effect is perhaps induced simply by exposure to xenobiotics. Consistent with this
hypothesis, mecamylamine exposure alone also induced drug resistance in the next generation,
although this effect was not as robust as that induced by nicotine or nicotine+mecamylamine (Fig-
ure 6). Together, these data demonstrate that drug resistance in sons can be induced by paternal
exposure to both nAChR agonists and nAChR antagonists, arguing that paternal xenobiotic expo-
sure is likely to be the relevant feature of our nicotine exposure paradigm.
Relative sparing of hepatocytes following drug treatments in NIC
offspring
Finally, we sought to understand the requirement for drug acclimation in revealing organismal drug
resistance in NIC offspring. Curiously, the relative upregulation of xenobiotic processing genes
(XPGs) in NIC offspring was observed in hepatocytes and livers isolated from ‘naı¨ve’ animals that
had not been exposed to nicotine or cocaine (Figure 4), yet enhanced resistance to toxins was only
observed in animals that were first acclimated to one of these drugs (Figures 3 and 5). To test the
hypothesis that XPG upregulation might be even stronger in NIC hepatocytes following drug
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exposure, we set out to characterize gene expression changes in nicotine- or cocaine-acclimated off-
spring. However, in attempting to isolate hepatocytes from drug-acclimated TA and NIC offspring
for RNA-Seq analysis, we noticed much poorer recovery of hepatocytes from TA than from NIC off-
spring (not shown), suggesting the possibility that NIC animals might be protected from drug-
induced hepatotoxicity. Therefore, to quantify cell viability in vivo, we took a histochemical approach
to assess apoptosis in livers from drug-acclimated TA and NIC offspring. Consistent with the rela-
tively poor recovery of hepatocytes from TA animals, we observed substantial hepatocyte death in
the livers of cocaine-exposed animals (Figure 7A). Importantly, while hepatocyte apoptosis and
necrosis were extremely common in livers from cocaine-exposed TA offspring, NIC offspring were
significantly protected from such cocaine toxicity (Figure 7). We conclude that the upregulation of
XPGs in naı¨ve NIC offspring is not sufficient to significantly protect animals from a lethal nicotine or
cocaine challenge, but that this upregulation can protect hepatocytes from sub-lethal doses of these
drugs. Following a week of chronic toxin exposure, TA offspring are left with substantially reduced
liver function, while NIC offspring maintain greater numbers of functional hepatocytes. We speculate
that this greater hepatocyte functional capacity, as well as the upregulation of XPGs in hepatocytes
(Figure 4), may both serve to protect the animal from a single toxic dose of xenobiotic.
Discussion
Here, we report a novel paradigm for intergenerational effects of paternal environment on offspring
phenotype, based on paternal nicotine administration. Our data reveal that paternal nicotine expo-
sure programs a state of nicotine resistance in offspring, but, surprisingly, neither the paternal sens-
ing machinery nor the offspring response are specific for nicotine.
Figure 6. Offspring drug resistance is induced by a nicotine antagonist. Here, we modified the paternal exposure
paradigm by implanting pumps to deliver the nicotine antagonist mecamylamine to male mice. Mecamylamine-
treated mice were provided with nicotine or control solution for four weeks, then mated to control females. Male
offspring were acclimated to chronic nicotine for six days and then subject to a toxic nicotine challenge, and
survival is shown as in Figures 3 and 5. Data for no mecamylamine animals are reproduced from Figure 3B. Note
that concurrent mecamylamine and nicotine exposure resulted in a protective effect on offspring, and even
mecamylamine alone was able to modestly induce nicotine resistance in the next generation.
DOI: 10.7554/eLife.24771.017
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Paternal nicotine exposure induces a pleiotropic, nonspecific set of
phenotypes in offspring
The use of nicotine, a well-characterized small molecule that acts in vivo by binding to specific recep-
tors, as the inciting paternal exposure enabled us to rigorously interrogate the specificity of the off-
spring response. Importantly, the enhanced toxin survival seen in offspring is not specific for the
drug to which fathers were exposed – NIC offspring were hyper-resistant to both nicotine and to
cocaine challenges – demonstrating that our paternal exposure paradigm does not result in trans-
mission of a nicotine-specific phenotype to progeny (at least for toxicity, locomotor effects, and
reward behavior). Mechanistically, the drug resistance observed in NIC offspring presumably results
from the enhanced hepatic drug clearance observed in these animals (Figure 4A). Consistent with
this increased nicotine clearance, isolated hepatocytes exhibited upregulation of a variety of xenobi-
otic processing genes (XPGs) accompanied by greater chromatin accessibility at relevant regulatory
regions. A variety of XPGs are induced in NIC hepatocytes in addition to those known to play a role
in nicotine clearance (Figure 4C), suggesting that NIC offspring may prove resistant to many toxins
beyond the two tested in this study.
In addition to the significant derepression of xenobiotic response genes observed in NIC off-
spring, we note that the most significant effects of paternal nicotine on offspring hepatocyte gene
expression occurred at metabolic genes (Figure 4C,E). This finding suggested that NIC offspring
might also exhibit metabolic alterations, in addition to the documented changes in xenobiotic resis-
tance. Alterations in glucose control and lipid metabolism are commonly observed in paternal effect
studies, being observed not only in dietary paradigms but also in some stress and toxin-related
paternal effect studies (Rando and Simmons, 2015), suggesting that multiple distinct stimuli
Figure 7. NIC offspring exhibit relative sparing of hepatocytes following chronic drug exposure. (A–B) Effects of
chronic cocaine treatment on hepatocyte viability. Two representative sections are shown for TUNEL-stained livers
from TA (A) and NIC (B) offspring following five days of cocaine injections (twice-daily, 15 mg/kg). Prominent
centrilobular apoptosis is seen in TA offspring, but is almost completely absent in NIC offspring. (C–D)
Quantitation of TUNEL staining data. (C) shows the average (plus/minus s.e.m.) number of TUNEL+ centrilobular
regions per slide (staining of >25% of central vein circumference was counted as TUNEL+, and was assessed at
five different levels for each liver lobe I-IV) for four individual TA (blue) and NIC (red) offspring, treated as in (A–B).
(D) shows data for all individual slides as dots, with boxplot showing median, one standard deviation, and 5th/95th
percentile for the 80 data points.
DOI: 10.7554/eLife.24771.018
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experienced by males might in some way convergently influence metabolic traits in offspring. As a
detailed metabolic phenotyping of NIC offspring is beyond the scope of this study, we chose here
to simply focus on the most common phenotype observed in other paternal effect experiments,
assaying glucose and insulin tolerance in TA and NIC offspring (Figure 4—figure supplement 2A–
B). Consistent with the ability of multiple paternal environments to alter glucose control in offspring,
we observed that NIC offspring exhibited significantly diminished clearance of a glucose bolus, as
well as a moderately diminished response to insulin.
Taken together, our data reveal (1) that paternal nicotine exposure induces a pleiotropic set of
phenotypes in male offspring, and (2) that the induced phenotypes in offspring are not specific for
nicotine. It will be of great interest in future studies to interrogate a wide variety of phenotypes in
offspring of males subject to a broad range of exposure paradigms – including stress, nicotine treat-
ment, and various diets – to identify common and divergent phenotypes induced by distinct paternal
exposure paradigms.
Paternal programming of offspring drug resistance is limited to male
offspring
A curious feature of many, but not all, paternal effect paradigms reported in mammals is that pheno-
typic effects often manifest preferentially in offspring of one gender. For example, while paternal
social defeat was reported to affect anxiety-related behavior in both male and female offspring,
locomotor activity and sucrose preference were only altered in male offspring (Dietz et al., 2011).
Here, we find that paternal nicotine exposure only affects drug resistance in male offspring, raising
once again the unsolved question of why paternal environments induce gender-specific outcomes in
progeny. Here, we consider three potential explanations for this phenomenon.
First, a subset of epigenetic information carriers – cytosine methylation and chromatin packaging
– are associated in cis with a specific genomic locus, meaning that epigenetic changes occurring on
the sex chromosomes will only affect progeny inheriting that chromosome. Thus, it is plausible that
nicotine exposure affects epigenetic modification of the Y chromosome to program drug resistance
in male offspring (or, less simply, that epigenetic marks on the X chromosome suppress an autoso-
mal or small RNA-directed phenotype that would otherwise affect both male and female progeny).
Second, X chromosome dosage compensation in mammals occurs via silencing of one of the two X
chromosomes in females. The inactive X chromosome could thus act as a ‘sink’ for epigenetic silenc-
ing machinery in females (Blewitt et al., 2005), such that the effective levels of this machinery avail-
able for autosomal gene regulation could differ between males and females. In this scenario,
paternal transmission of an epigenetically-marked autosomal locus, or RNA, could cause differential
effects in developing male vs. female offspring based on differences in the available levels of epige-
netic effector machinery. Finally, we note that an emerging theme in many paternal effect paradigms
is that the phenotypic changes observed in offspring are known to be regulated by various nuclear
hormone receptors (NHRs). For example, the phenotypes described in paternal stress paradigms are
related to glucocorticoid receptor signaling, while the metabolic gene expression changes resulting
from paternal dietary interventions exhibit significant overlap with genes regulated by NHRs such as
PPARa (Carone et al., 2010). Here, we find that paternal nicotine exposure affects hepatic expres-
sion of many targets of metabolic NHRs, as well as the xenobiotic-responsive NHRs CAR and PXR
(Figure 4). As sex hormones also act through NHR signaling – androgen receptor and estrogen
receptor – we speculate that levels or activity of NHR coactivators or corepressors could differ in
male vs. female progeny, resulting in altered penetrance or magnitude of paternal effects on NHR-
mediated gene regulation.
Offspring drug resistance is revealed by pre-exposure to xenobiotics
A crucial feature of the drug resistance exhibited by NIC offspring is that the toxin-resistant state is
only revealed by pre-exposure of these animals to xenobiotics. This requirement for drug pre-expo-
sure/acclimation emphasizes the key role of the offspring’s environment in the manifestation of an
epigenetically ‘reprogrammed’ phenotype. In other words, the development of an animal’s pheno-
type here involves an interaction between environmental conditions in two consecutive generations
(see (Rodgers et al., 2013; Zeybel et al., 2012) for similar examples) – as with gene X environment
effects, epigenetic marks also have context-dependent effects on organismal phenotype.
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What is the mechanism by which low level drug exposure enhances the survival of NIC offspring?
NIC hepatocytes exhibit derepression of xenobiotic response genes even before exposure to any
drugs, yet these drug-naı¨ve animals are no more resistant to nicotine or cocaine toxicity than control
animals (Figures 3A and 5A). Instead, the enhanced xenobiotic metabolism in NIC livers appears to
protect susceptible hepatocytes from toxicity during a course of sublethal drug exposure (Figure 7).
The loss of hepatocytes in drug-exposed TA animals presumably explains why fewer than 50% of
these animals survive an LD50 dose – calculated using drug-naı¨ve animals – of nicotine or cocaine
(Figures 3 and 5), with the preservation of hepatic capacity in NIC offspring preventing this degra-
dation in survivability. That said, not only do drug-acclimated NIC offspring simply preserve their sur-
vival in the face of an LD50 dose of these drugs, but they exhibit dramatically improved survival, as
far more than half of these animals survive this challenge. We have yet to uncover the mechanistic
basis for this enhanced survival, as RNA-Seq analysis of the hepatocytes isolated from drug-accli-
mated animals does not reveal further upregulation of XPGs than that documented for naı¨ve hepato-
cytes (not shown). Future studies will investigate whether drug acclimation might (1) affect mRNA
abundance in a limited subset of hepatocytes (which would be diluted out in whole liver or hepato-
cyte culture experiments), (2) affect mRNA abundance only transiently during drug exposure (and
not in cultured hepatocytes), leaving behind higher levels of the encoded proteins without an
mRNA-Seq signature, or (3) affect xenobiotic metabolism not at the level of mRNA abundance, but
post-transcriptionally.
How is nicotine sensed in exposed males?
The pleiotropic response observed in nicotine-exposed offspring raises the question of how nicotine
is sensed in the paternal generation in this system. A key question in this regard is whether stress
experienced by the nicotine-exposed males might be responsible for inducing the offspring pheno-
type, as it is known that a variety of paternal stress exposure paradigms – including early maternal
separation, social defeat stress, and chronic variable low level stress – affect multiple phenotypes in
offspring, from glucose control to anxiety-related behaviors (Bale, 2015). While we have not formally
ruled out a role for paternal stress in our system – it will of course be of interest to assay offspring
nicotine resistance in well-studied paternal stress paradigms – two findings strongly argue against
this paternal effect arising from a general stress response. First, chronic exposure to the nicotinic
receptor antagonist mecamylamine, which blocks nicotine dependence in nicotine-treated fathers,
does not interfere with induction of xenobiotic resistance in offspring (Figure 6), thus definitively rul-
ing out a role for paternal withdrawal stress in induction of this phenotype. This first point is further
supported by the finding that mecamylamine alone – which on its own has little effect on anxiety,
locomotor behavior, or physical withdrawal symptoms in nicotine-naı¨ve mice (Zhao-Shea et al.,
2013) – is sufficient to induce xenobiotic resistance in offspring. Second, in contrast to multiple
reported paternal stress paradigms, we do not find any evidence that paternal nicotine exposure
affects anxiety-related behavior in offspring (Figure 1—figure supplement 2).
What, then, is the relevant feature of nicotine in inducing xenobiotic resistance in offspring?
Paternal effects on toxin resistance in offspring did not require nicotinic receptor signaling, as both
nicotine itself as well as a nicotine antagonist were able to induce the protective response in off-
spring. As both nicotine and mecamylamine exposure can result in reduction of nAChR signaling via
desensitization or antagonism, respectively, it is formally possible that nAChR deactivation is the
inciting stimulus in the paternal generation (or, less likely, that the surgical stress of mecamylamine
infusion pump implantation, and nicotine consumption, both convergently induce the same effect in
offspring). However, we favor the simpler hypothesis that both of these molecules serve to program
offspring drug resistance via effects on paternal xenobiotic sensing. This model naturally raises the
question of how xenobiotic exposure is sensed. As a diverse variety of xenobiotics can affect gene
regulation via activation of the NHRs CAR and PXR, these NHRs represent appealing candidates for
the relevant xenobiotic sensor in fathers.
Whatever the nature of the relevant xenobiotic sensor, a key challenge to address is why experi-
mental exposure to nicotine or mecamylamine (or, presumably, many other xenobiotics) reprograms
offspring drug resistance relative to control animals, given that control animals are also exposed to a
multitude of small molecules even in controlled laboratory conditions. Do nicotine and mecamyl-
amine somehow induce a switch-like ‘all or none’ change in some epigenetic mark that is not present
in control sperm, or is the overall activity level of a xenobiotic sensor translated into quantitative
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changes in the levels of some continuous signal present in sperm? In the former case, what aspects
of a given exposure paradigm are required to induce alterations to the sperm epigenome? We offer
that one appealing mechanism for sensing increased levels of environmental xenobiotics would rely
on comparing changes in sensor activity over an animal’s lifetime. For instance, if CAR/PXR signaling
early in life – in utero perhaps, or early in postnatal life – were to result in a long-lasting ‘setpoint’ for
the levels of CAR/PXR activity expected later in life, then the organism could detect increased xeno-
biotic exposure later in life via changes in overall CAR/PXR activity compared to this setpoint. Future
studies will explore the nature of the ‘nicotine’ sensor in the paternal generation, and how informa-
tion about exposure history is transmitted to offspring.
Taken together, our studies define a novel paternal exposure paradigm based on a specific
ligand-receptor interaction, and show that paternal nicotine exposure programs offspring for
enhanced resistance to multiple distinct toxins. Our data also reveal broad metabolic gene expres-
sion changes in NIC offspring, with potential implications for metabolic and cardiovascular health of
offspring. Future studies will determine whether paternal nicotine exposure affects offspring via epi-
genetic marks in the sperm (vs. seminal fluid, etc.), and how paternally-transmitted information alters
the course of development to result in xenobiotic-resistant hepatocytes. It will also be of interest to
extend these studies to human populations, where the longer half-life of nicotine could potentially
result in self-administration phenotypes not observed in the mouse model.
Materials and methods
Animal husbandry and drug treatments
C57BL/6J mice (RRID:IMSR_JAX:000664), three weeks old, were obtained from Jackson labs on a
weekly basis and group-housed (four mice/cage) on a 12 hr light-dark cycle (7:00 A.M. to 7:00 P.M).
After arrival, males were immediately put on either tartaric acid (TA, 375 mg/ml) or nicotine (200 mg/
ml nicotine free-base) in drinking water for five consecutive weeks, followed by an additional week
on tap water prior to mating. Nicotine-exposed and control males were then allowed to mate (for
six days) with control females from the same shipment date. F1 offspring from nicotine-exposed and
control fathers were used for all experiments reported, generally at eight weeks of age unless other-
wise noted. Animals were maintained on-site in accordance with an approved IACUC protocol (A-
1788).
Locomotor assay
F1 males from nicotine-exposed and control fathers were pre-conditioned to handling and injections
with 0.9% saline (100 ml, i.p.) for three days prior to start of the study. For the nicotine test sessions,
animals were injected with nicotine and transferred to individual cages placed within an infrared pho-
tobeam frame (San Diego Instruments). Test sessions lasted 40 or 90 min per day for nine consecu-
tive days. Locomotor activity was defined as the number of beam breaks during a session,
whereupon the animal had to cross at least two photobeams from the original location to count as
ambulation. Results were statistically quantified using unpaired t-tests with multiple comparison
adjustment (Holm-Sidak correction).
Nicotine Self-Administration assay
Microsurgical catheter implant was performed on 7-week old F1 males from nicotine-exposed and
control fathers. Animals were anaesthetized with ketamine (100 mg/kg BW) and xylazine (10 mg/kg
BW) followed by a intrascapular and right midclavicular incision at the level of the carotid sheath.
Blunt preparation was used to create a subcutaneous canal between the two incisions. Subsequently,
the vena jugularis dextra was located and a catheter (2Fr, PV 10 cm, Instech Labs) was inserted and
gently pushed forward into the vena cava superior, where it remained for the length of the study.
The catheter was ligated to the vein using Ethibond Excel 4.0. The distal end of the catheter was
connected to a button (25 G, VAB, Instech. Labs), which was placed subcutaneously in an intrascapu-
lar position for easy access. After verifying that there was no leakage, the incision sites were closed
with Ethibond Excel 4.0. Through the catheter, the mouse was treated with heparin (15 I.U., Sigma-
Aldrich, St. Louis, MO) and an antibiotic mix of Ticarcillin (20 mg booster, Sigma-Aldrich) and Amika-
cin (10 mg/kg BW, Sigma-Aldrich). Animals received Ketoprofen (5 mg/kg BW, Sigma-Aldrich) once
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daily during a 3-day recovery phase. Afterwards, mice were put on a caloric restriction diet (85% w/
w of regular 24 hr consumption) three days prior to start of the experiment. We preconditioned ani-
mals on sucrose pellets in a 60 min session once a day for seven consecutive days, whereby animals
learned to nose-poke the active portal in a self-administration chamber in order to receive food
reward. The number of nose-pokes required to get a sucrose pellet escalated starting with a fixed
ratio of 1:1 (FR1) up to a fixed ratio of 5:1 (FR5). Only animals that had successfully been conditioned
on sucrose pellets advanced to the testing phase, during which they administered nicotine to them-
selves through the implanted catheter. Catheter patency was verified daily by aspiration of blood
and subsequent heparin infusion. Animals with blocked or dislocated catheters were excluded from
the study. The self-administered nicotine doses started with 0.03 mg/kg/injection for 4 days, then
0.1 mg/kg/injection for 8 days, 0.25 mg/kg/injection for 8 days, and 0.4 mg/kg/injection for 8 days.
The number of nose-pokes of the active versus the inactive portal, as well as the number of injections
administered, were recorded and analyzed using GraphPad Prism 7.0 and multiple t-tests with
Holm-Sidak correction. Survival was plotted as a Kaplan-Meier curve with significance levels calcu-
lated using modified Chi-square tests (Log-rank and Gehan-Breslow-Wilcoxon).
Cotinine assay
Blood of F1 males from nicotine-exposed or control fathers was collected in EDTA-coated tubes
after injection of 1.5 mg/kg nicotine free-base i.p. at 15 min, 30 min, and 45 min post-injection. Cel-
lular components were separated from serum by centrifugation at 12,000 g for 10 min. Cotinine
levels in serum of chronic F1s were measured using a Direct ELISA kit (CalBiotech Inc.). Samples
were run as two technical replicates together with a cotinine standard curve for each 96-well plate.
Analysis was performed using GraphPad Prism 7.
Anxiety assays
The elevated plus maze consisted of four arms connected by a central axis (5  5 cm) and was ele-
vated 45 cm above the floor. Two of the arms contained plastic black walls (5  30  15 cm) while
the other two remained open (5  30  0.25 cm). Mice were individually placed on the center of the
maze with their heads facing one of the open arms and allowed 5 min of free exploration. The num-
ber of entries into the open and closed arms, and the total time spent in the open and closed arms
was measured by MED-PC IV software (MED associates, Inc.).The apparatus was thoroughly cleaned
between animals. For activity in the open field, mice were placed in a rectangular arena made of
Plexiglas (40  40  30 cm) and mouse activity was video recorded for 10 min. Total activity, veloc-
ity, and time spent in the peripheral and central area of the open field was analyzed using video
tracking software (Noldus Ethovision).
cFos staining and cell count
F1 males from TA- and nicotine-exposed fathers were treated as for transcriptome analysis and phe-
notype studies. Briefly, animals received nicotine in their drinking water (200 mg/ml nicotine free-
base) for six consecutive days starting at seven weeks post-natum. Afterwards, mice were put on fil-
tered tap water from 12:00 P.M. until 7:00 A.M. the next day followed by immediate tissue collec-
tion. Brains of additional eight-week old control animals are dissected 90 min after i.p. injection of
1.5 mg/kg BW nicotine free-base. Animals were anesthetized with sodium pentobarbital i.p. (200
mg/kg BW) followed by intracardial infusion of 10 ml ice-cold PBS and 10 ml paraformaldehyde
(PFA; 4% w/v in PBS). Brains were kept at 4˚C in 4% PFA for 2 hr and then transferred into 30%
sucrose (w/v in PBS) until slice preparation.
Brains were sectioned using a microtome (Leica) into 25 mm slices and immersed in a 50% glyc-
erol, 50% ethylene glycol solution (Sigma) to preserve the tissue. Brain slices were stored in  20˚C
until further processing. Using the free-floating immunostaining method, slices were washed with
PBS for 5 min, permeabilized with 0.5% (v/v) Triton X-100 (Sigma) for 10 min, and blocked with 3%
donkey serum for 30 min. The slices were incubated overnight at 4˚C with antibodies against c-Fos
(1:1000, catalog number: sc-52, lot number: D2315, Santa Cruz Biotechnology, Santa Cruz, CA).
After washes with PBS, slices were incubated with Alexa Fluor 594 secondary antibodies (1:1000, ref
number: A21207, lot number: 1602780, Life Technologies, Carlsbad, CA). Counterstaining was car-
ried out with DAPI through mounting media (Cat number: H-1200, lot #: ZB0730, Vector, Burlington,
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CA). Fluorescent images were captured using an AxioCam MRm camera (Carl Zeiss, Peabody, MA)
attached to a Zeiss Axiovert inverted fluorescent microscope equipped with Zeiss filter sets 38HE,
49, and 20. Zeiss objectives A-p were subsequently processed using Axiovision version 4.8.2. Quanti-
fication of c-Fos-positive cells was performed using ImageJ, with a minimum of 6 hippocampal brain
slices analyzed per animal.
Tissue harvest for hippocampal mRNA-Seq
Seven week-old male F1 animals from control (TA) and nicotine-exposed fathers were divided into
three treatment groups: naı¨ve, chronic, and chronic + stimulation. Naı¨ve mice were not exposed to
nicotine before tissue collection at 8 weeks of age. Chronic animals received nicotine in their drink-
ing water (200 mg/ml) for six consecutive days. Afterwards, chronic mice were put on filtered tap
water from 12:00 P.M. until 7:00 A.M. the next day followed by tissue collection as for naı¨ve animals.
Chronic + stimulation animals were treated as chronic animals, but received an additional nicotine
injection (1.5 mg/kg BW nicotine free base i.p.) 30 min before organ harvest. For all three sets of ani-
mals, following sacrifice brains were explanted and put on ice. A midline incision was executed and
midbrain, hypothalamus, and hippocampus of either side were dissected. Tissues were immediately
immersed in liquid nitrogen, then stored at  80˚C until further processing.
Hepatocyte isolation for mRNA-Seq and for ATAC-Seq
Eight week-old male F1 animals from control (TA) and nicotine-exposed fathers were anaesthetized
using ketamine (100 mg/kg BW) and xylazine (10 mg/kg BW). The abdominal cavity was opened
with a transverse incision below the rib cage. The portal vein was dissected with blunt forceps and a
26 G catheter needle was inserted. After cutting the vena cava inferior cranial of the liver, the organ
was perfused firstly with 1X HBBS +200 mM EDTA (10 ml at 7 ml/min) and secondly with 50 ml
DMEM containing collagenase type I (0.4 mg/ml) at 7 ml/min. The liver was then removed from the
abdominal cavity, put in a petri dish containing culture medium (DMEM, 20% FBS, 1X ITS, 1X Penicil-
lin/Streptomycin, 0.1 mM Dexamethasone, Sigma-Aldrich), and gently dissected to allow release of
hepatocytes and supporting cells from connective tissue. Note that due to the disaggregation of the
entire liver, mRNA abundance changes observed in a subset of hepatocytes (such as, for example,
dying cells in drug-acclimated animals – Figure 7) will be diluted out by the majority of unaffected
hepatocytes. After filtration through a 70 mm nylon cell strainer, cells were washed twice with PBS
1X and once with culture media (centrifugation at 500 rpm for 5 min), and plated on a 0.1% gelatin-
coated well. Hepatocytes were allowed to adhere to the bottom of the well for three hours. Nonad-
herent cells were then removed, and fresh culture medium was then added, initiating our time
course (T0, T1, T3, T21 hours). Cells were collected after a PBS 1X wash by adding TriZol to the well
for RNA experiments.
RNA-Seq
Strand-specific libraries were prepared as previously described (Zhang et al., 2012). Briefly, brain
and liver were collected from nicotine-exposed and control F1 males. Hepatocytes were isolated as
described above. For the hippocampus, after sectioning of brain into 1 mm slices, areas of interest
were identified according to the Mouse Brain Atlas by Paxinos and Franklin and dissected using
0.5 mm punches.
RNA from brain and liver was isolated using standard TriZol protocols, followed by rRNA deple-
tion (RiboZero kit, Illumina, Inc.). After first- and second-strand synthesis, adapters were ligated to
fragments and amplified using multiplexed PCR primers. Libraries were sequenced on a NextSeq
500 platform from Illumina, Inc. Quality-controlled reads were aligned to the reference genome
(Mus musculus/mm10) with Bowtie2 and differential expression was calculated using DESeq2. For
multiple comparison adjustments, we used Holm-Bonferroni correction as a more conservative
approach.
RNA-Seq data are available at GEO, accession # GSE94059.
ATAC-Seq
ATAC-seq libraries were prepared for 16 hepatocyte samples (4 NIC and 4 TA animals, with each
sample split into untreated and dexamethasone-treated aliquots) as previously described
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(Buenrostro et al., 2015) using the Nextera DNA Library Preparation Kit (Illumina). Libraries were
paired-end sequenced on a NextSeq 500, and reads were aligned to mm10 using Bowtie2, v2–2.1.0
with the parameters -D 15 R 2 N 1 L 20 -i S,1,0.50 –maxins 2000 –no-discordant –no-mixed. Mito-
chondrial DNA and random chromosome mapped reads were removed, and PCR duplicates were
removed. Genome browser images were generated from merged datasets with reads extended to
150 bp, and normalized by total mapped reads per sample. For differential peak analysis, HOMER
was used to identify NIC-specific peaks using TA peak files as background.
ATAC-Seq data are available at GEO, accession # GSE92240.
Liver histology
Livers were harvested from F1 males from nicotine-exposed and control fathers under various condi-
tions (pre-treatment with nicotine 1.5 mg/kg BW intraperitoneal b.i.d. for five days or cocaine 15
mg/kg BW intraperitoneal b.i.d. or acetaminophen 400 mg/kg BW q.d. for one day) and washed
with PBS. A 4 mm slice was taken from each lobe and put in ice-cold 4% formaldehyde overnight.
The next day, samples were dehydrated in a series of escalating ethanol solutions starting with 70%
and ending with 100%, embedded in paraffin, and sectioned (4 mm slices), each section containing
all four lobes, which were then mounted onto a glass slide. For H/E staining, slices were de-parafi-
nized, incubated with xylene and a series of descending ethanol solutions. Incubation times for
Mayer’s hematoxylin (Sigma-Aldrich) and 1% Eosin Y (Sigma-Aldrich) were 30 s and 20 s, respec-
tively. After dewaxing of tissue, TUNEL staining was performed following the manufacturer’s recom-
mendations (in Situ Cell Death Detection Kit, POD, Roche). Apoptotic areas per lobe were counted
under a light microscope with 20X magnification at five different levels through the sample and ana-
lyzed with Image J.
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